Xiao‐cong Zuo

1.3k total citations
59 papers, 929 citations indexed

About

Xiao‐cong Zuo is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Pharmacology. According to data from OpenAlex, Xiao‐cong Zuo has authored 59 papers receiving a total of 929 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Nephrology, 11 papers in Cardiology and Cardiovascular Medicine and 10 papers in Pharmacology. Recurrent topics in Xiao‐cong Zuo's work include Acute Kidney Injury Research (15 papers), Chronic Kidney Disease and Diabetes (10 papers) and Pharmacological Effects and Toxicity Studies (10 papers). Xiao‐cong Zuo is often cited by papers focused on Acute Kidney Injury Research (15 papers), Chronic Kidney Disease and Diabetes (10 papers) and Pharmacological Effects and Toxicity Studies (10 papers). Xiao‐cong Zuo collaborates with scholars based in China and United States. Xiao‐cong Zuo's co-authors include Jianglin Wang, Wenjun Yin, Lingyun Zhou, Xiaofeng Guan, Qingjie Chen, Can Hu, Guoping Yang, Bikui Zhang, Kun Liu and Shanru Zuo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Chemical Engineering Journal and Kidney International.

In The Last Decade

Xiao‐cong Zuo

58 papers receiving 914 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiao‐cong Zuo China 16 220 137 137 130 126 59 929
H.-H. Neumayer Germany 18 326 1.5× 126 0.9× 315 2.3× 208 1.6× 89 0.7× 43 1.3k
Osama Gheith Egypt 15 332 1.5× 58 0.4× 301 2.2× 149 1.1× 191 1.5× 109 1.3k
Myrna Y. Munar United States 18 58 0.3× 215 1.6× 127 0.9× 290 2.2× 151 1.2× 35 1.2k
Ali Akçay Türkiye 23 652 3.0× 74 0.5× 69 0.5× 183 1.4× 211 1.7× 63 1.6k
Petr Bachleda Czechia 17 62 0.3× 79 0.6× 136 1.0× 119 0.9× 84 0.7× 91 837
K. H. Rahn Germany 18 151 0.7× 75 0.5× 120 0.9× 108 0.8× 72 0.6× 56 1.2k
Chantal Barin‐Le Guellec France 14 40 0.2× 114 0.8× 73 0.5× 115 0.9× 55 0.4× 36 545
Simon de Denus Canada 24 44 0.2× 119 0.9× 77 0.6× 130 1.0× 168 1.3× 96 1.9k
Tripti Singh United States 18 179 0.8× 22 0.2× 136 1.0× 362 2.8× 90 0.7× 68 1.3k
Yu Ah Hong South Korea 18 459 2.1× 38 0.3× 81 0.6× 415 3.2× 215 1.7× 83 1.4k

Countries citing papers authored by Xiao‐cong Zuo

Since Specialization
Citations

This map shows the geographic impact of Xiao‐cong Zuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao‐cong Zuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao‐cong Zuo more than expected).

Fields of papers citing papers by Xiao‐cong Zuo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao‐cong Zuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao‐cong Zuo. The network helps show where Xiao‐cong Zuo may publish in the future.

Co-authorship network of co-authors of Xiao‐cong Zuo

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao‐cong Zuo. A scholar is included among the top collaborators of Xiao‐cong Zuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao‐cong Zuo. Xiao‐cong Zuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Lingyun, Wenjun Yin, Yingcai Meng, et al.. (2024). A renal-targeted gene delivery system derived from spermidine for arginase-2 silencing and synergistic attenuation of drug-induced acute kidney injury. Chemical Engineering Journal. 486. 150125–150125. 9 indexed citations
2.
Yin, Wenjun, Xiaoqing Lin, Hai‐long Piao, et al.. (2024). Hypoalbuminemia and cisplatin-induced acute kidney injury. Frontiers in Pharmacology. 15. 1510477–1510477. 2 indexed citations
3.
Wu, Yifeng, et al.. (2024). Identification and analysis of differently expressed transcription factors in aristolochic acid nephropathy. Environmental Health and Preventive Medicine. 29(0). 30–30. 1 indexed citations
4.
Yin, Wenjun, et al.. (2024). A pilot clinical risk model to predict polymyxin-induced nephrotoxicity: a real-world, retrospective cohort study. Journal of Antimicrobial Chemotherapy. 79(8). 1919–1928. 3 indexed citations
5.
Zuo, Xiao‐cong, et al.. (2024). Acute kidney injury with intravenous colistin sulfate compared with polymyxin B in critically ill patients: A real‐world, retrospective cohort study. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 44(8). 631–641. 5 indexed citations
6.
Wang, Jianglin, Lingyun Zhou, Wenjun Yin, Can Hu, & Xiao‐cong Zuo. (2023). Trends of the burden of type 2 diabetes mellitus attributable to high body mass index from 1990 to 2019 in China. Frontiers in Endocrinology. 14. 1193884–1193884. 8 indexed citations
7.
Liu, Kun, Zhiyao Tang, Yifeng Wu, et al.. (2023). Identification and validation of hub genes in drug induced acute kidney injury basing on integrated transcriptomic analysis. Frontiers in Immunology. 14. 1126348–1126348. 9 indexed citations
8.
Wang, Jianglin, Xin Hu, Wei Jiang, et al.. (2023). Analysis of the clinical characteristics of pembrolizumab-induced bullous pemphigoid. Frontiers in Oncology. 13. 1095694–1095694. 9 indexed citations
9.
Wang, Jianglin, et al.. (2022). Prevalence of polymyxin-induced nephrotoxicity and its predictors in critically ill adult patients: A meta-analysis. World Journal of Clinical Cases. 10(31). 11466–11485. 10 indexed citations
10.
11.
Zhou, Lingyun, Wenjing Cheng, Wenjun Yin, et al.. (2019). A novel rat model of contrast-induced nephropathy based on dehydration. Journal of Pharmacological Sciences. 141(1). 49–55. 13 indexed citations
12.
Zuo, Shanru, Xiao‐cong Zuo, Yang He, et al.. (2017). Positive Expression of SMYD2 is Associated with Poor Prognosis in Patients with Primary Hepatocellular Carcinoma. Journal of Cancer. 9(2). 321–330. 36 indexed citations
13.
Guan, Xiaofeng, Qingjie Chen, Xiao‐cong Zuo, et al.. (2016). Contrast Media-Induced Renal Inflammation Is Mediated Through HMGB1 and Its Receptors in Human Tubular Cells. DNA and Cell Biology. 36(1). 67–76. 25 indexed citations
14.
Pei, Qi, Jie Huang, Jingkai Gu, et al.. (2016). Influences of CYP2D6*10 polymorphisms on the pharmacokinetics of iloperidone and its metabolites in Chinese patients with schizophrenia: a population pharmacokinetic analysis. Acta Pharmacologica Sinica. 37(11). 1499–1508. 9 indexed citations
15.
Chen, Qingjie, Jing Li, Shanru Zuo, et al.. (2015). Tacrolimus decreases insulin sensitivity without reducing fasting insulin concentration: a 2-year follow-up study in kidney transplant recipients. Renal Failure. 37(4). 601–606. 13 indexed citations
16.
Zuo, Xiao‐cong, Wenli Zhang, Hong Yuan, et al.. (2014). ABCB1 Polymorphism and Gender Affect the Pharmacokinetics of Amlodipine in Chinese Patients with Essential Hypertension: A Population Analysis. Drug Metabolism and Pharmacokinetics. 29(4). 305–311. 17 indexed citations
17.
Zuo, Xiao‐cong, Chee M. Ng, Jeffrey S. Barrett, et al.. (2013). Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients. Pharmacogenetics and Genomics. 23(5). 251–261. 108 indexed citations
18.
Zuo, Xiao‐cong. (2012). Progress on the relationship between chemerin and glucose and lipid metabolism. The Chinese Journal of Clinical Pharmacology. 1 indexed citations
19.
Cai, Jingjing, Zhijun Huang, Guoping Yang, et al.. (2011). Comparing Antihypertensive Effect and Plasma Ciclosporin Concentration between Amlodipine and Valsartan Regimens in Hypertensive Renal Transplant Patients Receiving Ciclosporin Therapy. American Journal of Cardiovascular Drugs. 11(6). 401–409. 12 indexed citations
20.
Zuo, Xiao‐cong, et al.. (2006). Steady-state pharmacokinetic properties of aripiprazole 10 mg PO g12h in Han Chinese adults with schizophrenia: A prospective, open-label, pilot study. Current Therapeutic Research. 67(4). 258–269. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026